Literature DB >> 27166131

Radiological Response Is Associated With Better Long-Term Outcomes and Is a Potential Treatment Target in Patients With Small Bowel Crohn's Disease.

Parakkal Deepak1, Joel G Fletcher2, Jeff L Fidler2, John M Barlow2, Shannon P Sheedy2, Amy B Kolbe3, William S Harmsen4, Edward V Loftus1, Stephanie L Hansel1, Brenda D Becker1, David H Bruining1.   

Abstract

OBJECTIVES: Crohn's disease (CD) management targets mucosal healing on ileocolonoscopy as a treatment goal. We hypothesized that radiologic response is also associated with better long-term outcomes.
METHODS: Small bowel CD patients between 1 January 2002 and 31 October 2014 were identified. All patients had pre-therapy computed tomography enterography (CTE)/magnetic resonance enterography (MRE) with follow-up CTE or MRE after 6 months, or 2 CTE/MREs≥6 months apart while on maintenance therapy. Radiologists characterized inflammation in up to five small bowel lesions per patient. At second CTE/MRE, complete responders had all improved lesions, non-responders had worsening or new lesions, and partial responders had other scenarios. CD-related outcomes of corticosteroid usage, hospitalization, and surgery were assessed using Kaplan-Meier survival analysis and multivariable Cox models.
RESULTS: CD patients (n=150), with a median disease duration of 9 years, had 223 inflamed small bowel segments (76 with strictures and 62 with penetrating, non-perianal disease), 49% having ileal distribution. Fifty-five patients (37%) were complete radiologic responders, 39 partial (26%), and 56 non-responders (37%). In multivariable Cox models, complete and partial response decreased risk for steroid usage by over 50% (hazard ratio (HR)s: 0.37 (95% confidence interval (CI), 0.21-0.64); 0.45 (95% CI, 0.26-0.79)), and complete response decreased the risk of subsequent hospitalizations and surgery by over two-thirds (HRs: HR, 0.28 (95% CI, 0.15-0.50); HR, 0.34 (95% CI, 0.18-0.63)).
CONCLUSIONS: Radiological response to medical therapy is associated with significant reductions in long-term risk of hospitalization, surgery, or corticosteroid usage among small bowel CD patients. These findings suggest the significance of radiological response as a treatment target.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27166131     DOI: 10.1038/ajg.2016.177

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  37 in total

1.  Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease.

Authors:  Abderrahim Oussalah; Valérie Laurent; Olivier Bruot; Aude Bressenot; Marc-André Bigard; Denis Régent; Laurent Peyrin-Biroulet
Journal:  Gut       Date:  2010-06-04       Impact factor: 23.059

2.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.

Authors:  Mark S Silverberg; Jack Satsangi; Tariq Ahmad; Ian D R Arnott; Charles N Bernstein; Steven R Brant; Renzo Caprilli; Jean-Frédéric Colombel; Christoph Gasche; Karel Geboes; Derek P Jewell; Amir Karban; Edward V Loftus; A Salvador Peña; Robert H Riddell; David B Sachar; Stefan Schreiber; A Hillary Steinhart; Stephan R Targan; Severine Vermeire; B F Warren
Journal:  Can J Gastroenterol       Date:  2005-09       Impact factor: 3.522

3.  EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) study identifies fecal calprotectin, serum MMP9, and serum IL-22 as a novel combination of biomarkers for Crohn's disease activity: role of cross-sectional imaging.

Authors:  William A Faubion; Joel G Fletcher; Sharon O'Byrne; Brian G Feagan; Willem Js de Villiers; Bruce Salzberg; Scott Plevy; Deborah D Proctor; John F Valentine; Peter D Higgins; Jeffrey M Harris; Lauri Diehl; Lilyan Wright; Gaik Wei Tew; Diana Luca; Karen Basu; Mary E Keir
Journal:  Am J Gastroenterol       Date:  2013-10-15       Impact factor: 10.864

4.  Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines.

Authors:  J Panes; Y Bouhnik; W Reinisch; J Stoker; S A Taylor; D C Baumgart; S Danese; S Halligan; B Marincek; C Matos; L Peyrin-Biroulet; J Rimola; G Rogler; G van Assche; S Ardizzone; A Ba-Ssalamah; M A Bali; D Bellini; L Biancone; F Castiglione; R Ehehalt; R Grassi; T Kucharzik; F Maccioni; G Maconi; F Magro; J Martín-Comín; G Morana; D Pendsé; S Sebastian; A Signore; D Tolan; J A Tielbeek; D Weishaupt; B Wiarda; A Laghi
Journal:  J Crohns Colitis       Date:  2013-04-11       Impact factor: 9.071

5.  Non-perforating small bowel Crohn's disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index.

Authors:  Michael J Steward; Shonit Punwani; Ian Proctor; Yvette Adjei-Gyamfi; Fiona Chatterjee; Stuart Bloom; Marco Novelli; Steve Halligan; Manuel Rodriguez-Justo; Stuart A Taylor
Journal:  Eur J Radiol       Date:  2011-09-15       Impact factor: 3.528

6.  Adalimumab induces deep remission in patients with Crohn's disease.

Authors:  Jean-Frédéric Colombel; Paul J Rutgeerts; William J Sandborn; Mei Yang; Anne Camez; Paul F Pollack; Roopal B Thakkar; Anne M Robinson; Naijun Chen; Parvez M Mulani; Jingdong Chao
Journal:  Clin Gastroenterol Hepatol       Date:  2013-07-12       Impact factor: 11.382

7.  Benefit of computed tomography enterography in Crohn's disease: effects on patient management and physician level of confidence.

Authors:  David H Bruining; Hassan A Siddiki; Joel G Fletcher; William J Sandborn; Jeff L Fidler; James E Huprich; Jayawant N Mandrekar; William S Harmsen; Paul E Evans; William A Faubion; Karen A Hanson; Steven B Ingle; Darrell S Pardi; Kenneth W Schroeder; William J Tremaine; Edward V Loftus
Journal:  Inflamm Bowel Dis       Date:  2011-02-17       Impact factor: 5.325

8.  Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease.

Authors:  Fabian Schnitzler; Herma Fidder; Marc Ferrante; Maja Noman; Ingrid Arijs; Gert Van Assche; Ilse Hoffman; Kristel Van Steen; Séverine Vermeire; Paul Rutgeerts
Journal:  Inflamm Bowel Dis       Date:  2009-09       Impact factor: 5.325

Review 9.  Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

Authors:  L Peyrin-Biroulet; W Sandborn; B E Sands; W Reinisch; W Bemelman; R V Bryant; G D'Haens; I Dotan; M Dubinsky; B Feagan; G Fiorino; R Gearry; S Krishnareddy; P L Lakatos; E V Loftus; P Marteau; P Munkholm; T B Murdoch; I Ordás; R Panaccione; R H Riddell; J Ruel; D T Rubin; M Samaan; C A Siegel; M S Silverberg; J Stoker; S Schreiber; S Travis; G Van Assche; S Danese; J Panes; G Bouguen; S O'Donnell; B Pariente; S Winer; S Hanauer; J-F Colombel
Journal:  Am J Gastroenterol       Date:  2015-08-25       Impact factor: 10.864

10.  Enteroclysis CT and PEG-CT in patients with previous small-bowel surgical resection for Crohn's disease: CT findings and correlation with endoscopy.

Authors:  Laura Maria Minordi; Amorino Vecchioli; Giuliana Poloni; Luisa Guidi; Italo De Vitis; Lorenzo Bonomo
Journal:  Eur Radiol       Date:  2009-05-05       Impact factor: 5.315

View more
  22 in total

1.  Bowel wall healing assessed using magnetic resonance imaging predicts sustained clinical remission and decreased risk of surgery in Crohn's disease.

Authors:  Anthony Buisson; Constance Hordonneau; Felix Goutorbe; Christophe Allimant; Marion Goutte; Maud Reymond; Bruno Pereira; Gilles Bommelaer
Journal:  J Gastroenterol       Date:  2018-08-30       Impact factor: 7.527

2.  Targeting Mucosal Healing in Crohn's Disease.

Authors:  Michael F Picco; Francis A Farraye
Journal:  Gastroenterol Hepatol (N Y)       Date:  2019-10

3.  Predictors of Durability of Radiological Response in Patients With Small Bowel Crohn's Disease.

Authors:  Parakkal Deepak; Joel G Fletcher; Jeff L Fidler; John M Barlow; Shannon P Sheedy; Amy B Kolbe; William S Harmsen; Terry Therneau; Stephanie L Hansel; Brenda D Becker; Edward V Loftus; David H Bruining
Journal:  Inflamm Bowel Dis       Date:  2018-07-12       Impact factor: 5.325

4.  Clinical Impact of Sonographic Transmural Healing After Anti-TNF Antibody Treatment in Patients with Crohn's Disease.

Authors:  José María Paredes; Nadia Moreno; Patricia Latorre; Tomás Ripollés; María Jesús Martinez; José Vizuete; Eduardo Moreno-Osset
Journal:  Dig Dis Sci       Date:  2019-03-14       Impact factor: 3.199

5.  Creeping Fat Assessed by Small Bowel MRI Is Linked to Bowel Damage and Abdominal Surgery in Crohn's Disease.

Authors:  Patrick Althoff; Wolff Schmiegel; Gernot Lang; Volkmar Nicolas; Thorsten Brechmann
Journal:  Dig Dis Sci       Date:  2018-10-01       Impact factor: 3.199

Review 6.  Computed Tomography and Magnetic Resonance Enterography in Crohn's Disease: Assessment of Radiologic Criteria and Endpoints for Clinical Practice and Trials.

Authors:  Parakkal Deepak; Joel G Fletcher; Jeff L Fidler; David H Bruining
Journal:  Inflamm Bowel Dis       Date:  2016-09       Impact factor: 5.325

7.  ACG Clinical Guideline: Management of Crohn's Disease in Adults.

Authors:  Gary R Lichtenstein; Edward V Loftus; Kim L Isaacs; Miguel D Regueiro; Lauren B Gerson; Bruce E Sands
Journal:  Am J Gastroenterol       Date:  2018-03-27       Impact factor: 10.864

8.  Assessing Small Bowel Stricturing and Morphology in Crohn's Disease Using Semi-automated Image Analysis.

Authors:  Ryan W Stidham; Binu Enchakalody; Akbar K Waljee; Peter D R Higgins; Stewart C Wang; Grace L Su; Ashish P Wasnik; Mahmoud Al-Hawary
Journal:  Inflamm Bowel Dis       Date:  2020-04-11       Impact factor: 5.325

9.  Magnetic resonance enterography features of small bowel Crohn's disease activity: an inter-rater reliability study of small bowel active inflammation in clinical practice setting.

Authors:  Richard Tsai; Aaron Mintz; Michael Lin; Joyce Mhlanga; Adeeti Chiplunker; Amber Salter; Matthew Ciorba; Parakkal Deepak; Kathryn Fowler
Journal:  Br J Radiol       Date:  2019-05-29       Impact factor: 3.039

10.  Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn's Disease.

Authors:  Remo Panaccione; A Hillary Steinhart; Brian Bressler; Reena Khanna; John K Marshall; Laura Targownik; Waqqas Afif; Alain Bitton; Mark Borgaonkar; Usha Chauhan; Brendan Halloran; Jennifer Jones; Erin Kennedy; Grigorios I Leontiadis; Edward V Loftus; Jonathan Meddings; Paul Moayyedi; Sanjay Murthy; Sophie Plamondon; Greg Rosenfeld; David Schwartz; Cynthia H Seow; Chadwick Williams; Charles N Bernstein
Journal:  J Can Assoc Gastroenterol       Date:  2018-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.